Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

There’s still scope for a new generation of drugs to replace weight-loss market leaders like Novo Nordisk A/S’s Wegovy, ...

Eli Lilly's popular obesity drug Zepbound can now be covered by government-backed Medicare drug plans, CNBC reported on ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

In Tuesday's issue of The Lancet Diabetes & Endocrinology, dozens of international medical experts and people with lived ...

A new report says only using BMI to determine if a patient has obesity leads to under-diagnosing people who are ill and ...